PDA (Pentadecapeptide Arginate)

—

evidence score

peptide

Prescription Only

PDABPC-157 ArginatePentadecapeptide Arginate

Structural analog of BPC-157 with arginine salt form. Similar tissue repair and anti-inflammatory mechanisms. Currently the primary available replacement for BPC-157 while it awaits FDA reclassification.

Evidence

No score yet

Safety

Unknown safety profile

Clinical Status

No formal trials

Last Sync

Not synced yet

Last Reviewed

Not reviewed yet

Physician Notes

Use this instead of BPC-157 until BPC-157 is formally reclassified. 250-500mcg daily, 5 on/2 off. Include in the bedtime body composition stack (PDA + Ipamorelin + Tesamorelin).

FDA Status:Currently available via 503A pharmacies. Primary replacement for BPC-157.

Monitoring

Clinical assessment of healing response

Contraindications

Active cancer (theoretical)

Velix Health

Want this prescribed by a board-certified physician?

Velix Health physicians review your labs, build evidence-based protocols, and monitor your progress. Every prescription is referenced.

Apply for Membership

Dosing

Typical

500 mcg

250 mcgRange500 mcg

FrequencyDaily (5 on / 2 off)

Set height & weight in Settings to see your dose.

Pharmacology

Half-lifeMinutes (tissue effects persist)

OnsetDays to weeks depending on injury

Routes

subcutaneous_injection

Evidence Score

—

0 studies indexed

Scoring Factors

Volume(24%)—

Quality(24%)—

Sample Size(12%)—

Consistency(14%)—

Replication(8%)—

Recency(18%)—

Evidence Levels

AScore ≥75 with at least 1 meta-analysis and 3+ RCTs

BScore ≥50 with at least 1 RCT or meta-analysis

CScore ≥25 — observational or animal evidence only

DScore <25 — very limited or preclinical data

Plain-English Snapshot

PDA (Pentadecapeptide Arginate) is currently categorized as a peptide compound.

Evidence scoring has not been fully computed yet, so interpret this profile as preliminary.

Safety scoring is incomplete. Start conservatively and monitor carefully.

Core mechanism

BPC-157 structural replacement; tissue repair via angiogenesis and GH receptor upregulation

Practical Context

Strongest current signals

No indexed study summaries yet.